Intracellular cytokines in the acute response to highly active antiretroviral therapy

AIDS

Volumn 15, Issue 13, 2001, Pages 1665-1670

  Lew, Edward ^a   Gallagher, Laura ^b   Kuehnert, Matthew ^c   Rimland, David ^b   Hubbard, Marjorie ^a   Parekh, Bharat ^a   Zell, Elisabeth ^a   Jarvis, William ^c   Jason, Janine ^a,d  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

AIDS; AIDS therapy; Cytokines; HAART; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; EFAVIRENZ; INDINAVIR; INTERLEUKIN 4; LAMIVUDINE; NELFINAVIR; RITONAVIR; STAVUDINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-4; MALE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035822953     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200109070-00009     Document Type: Article

References (20)

1. Cytokines and the human immunodeficiency virus: From bench to bedside
2. Enhancement of HIV replication and giant cell formation by tumor necrosis factor
3. Augmentation of in vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumour necrosis factor
4. A Th1 → Th2 switch is a critical step in the etiology of HIV infection
5. The Th1-Th2 hypothesis of HIV infection: New insights
6. Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection
7. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
8. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
9. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease
10. T cell changes after combined nucleoside analogue therapy in HIV primary infection
11. Single-cell cytokine profiles in normal humans: Comparison of flow cytometric reagents and stimulation protocols
12. Natural T, gamma delta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infection
13. Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus infected patients after 9 months of highly active antiretroviral therapy
14. NF-kappaB: A pleiotropic mediator of inducible and tissue specific gene control
15. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses
16. Cytokines and HIV infection: Is AIDS a tumor necrosis factor disease?
17. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure
18. T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under non-stimulated conditions
19. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: Impact of highly active antiretroviral therapy
20. Early reduction of immune activation in lymphoid tissue following highly active HIV